Petit T - Search Results

1

Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer.

Petit T, Benider A, Yovine A, Bougnoux P, Spaeth D, Maindrault-Goebel F, Serin D, Tigaud JD, Eymard JC, Simon H, Bertaux B, Brienza S, Cvitkovic E. Petit T, et al. Anticancer Drugs. 2006 Mar;17(3):337-43. doi: 10.1097/00001813-200603000-00013. Anticancer Drugs. 2006. PMID: 16520663 Clinical Trial.

2

Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II study.

Campone M, Fumoleau P, Viens P, Diéras V, Pujade-Lauraine E, Serin D, Petit T, Espié M, Kayitalire L, Bozec L, Pouillart P. Campone M, et al. Among authors: petit t. Breast. 2006 Oct;15(5):601-9. doi: 10.1016/j.breast.2005.11.010. Breast. 2006. PMID: 17045160 Clinical Trial.

3

A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients.

Viens P, Petit T, Yovine A, Bougnoux P, Deplanque G, Cottu PH, Delva R, Lotz JP, Belle SV, Extra JM, Cvitkovic E. Viens P, et al. Among authors: petit t. Ann Oncol. 2006 Mar;17(3):429-36. doi: 10.1093/annonc/mdj097. Ann Oncol. 2006. PMID: 16500913 Free article. Clinical Trial.

4

Randomized multicentric study of perioperative chemotherapy with mitoxantrone in early breast cancer.

Petit T, Borel C, Theobald S, Serin D, Rodier JF, Prevot G, Brettes JP, Klein T. Petit T, et al. Ann Surg Oncol. 2003 May;10(4):369-75. doi: 10.1245/aso.2003.07.015. Ann Surg Oncol. 2003. PMID: 12734084 Clinical Trial.

5

Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial.

Coudert B, Pierga JY, Mouret-Reynier MA, Kerrou K, Ferrero JM, Petit T, Kerbrat P, Dupré PF, Bachelot T, Gabelle P, Giard S, Coeffic D, Bougnoux P, Prevost JB, Paintaud G, Thibault G, Hernandez J, Coudert M, Arnould L, Berriolo-Riedinger A. Coudert B, et al. Among authors: petit t. Lancet Oncol. 2014 Dec;15(13):1493-1502. doi: 10.1016/S1470-2045(14)70475-9. Epub 2014 Oct 30. Lancet Oncol. 2014. PMID: 25456368 Clinical Trial.

6

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patients.

Dieras V, Bougnoux P, Petit T, Chollet P, Beuzeboc P, Borel C, Husseini F, Goupil A, Kerbrat P, Misset JL, Bensmaïne MA, Tabah-Fisch I, Pouillart P. Dieras V, et al. Among authors: petit t. Ann Oncol. 2002 Feb;13(2):258-66. doi: 10.1093/annonc/mdf018. Ann Oncol. 2002. PMID: 11886003 Free article. Clinical Trial.

7

Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074).

Pautier P, Joly F, Kerbrat P, Bougnoux P, Fumoleau P, Petit T, Rixe O, Ringeisen F, Carrasco AT, Lhommé C. Pautier P, et al. Among authors: petit t. Gynecol Oncol. 2010 Feb;116(2):157-62. doi: 10.1016/j.ygyno.2009.10.076. Gynecol Oncol. 2010. PMID: 20109725 Clinical Trial.

8

Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.

Frasca M, Sabathe C, Delaloge S, Galvin A, Patsouris A, Levy C, Mouret-Reynier MA, Desmoulins I, Vanlemmens L, Bachelot T, Goncalves A, Perotin V, Uwer L, Frenel JS, Ferrero JM, Bouleuc C, Eymard JC, Dieras V, Leheurteur M, Petit T, Dalenc F, Jaffre A, Chevrot M, Courtinard C, Mathoulin-Pelissier S. Frasca M, et al. Among authors: petit t. Eur J Cancer. 2020 Sep;137:240-249. doi: 10.1016/j.ejca.2020.07.007. Epub 2020 Aug 14. Eur J Cancer. 2020. PMID: 32805641

9

Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer.

Mallet A, Lusque A, Levy C, Pistilli B, Brain E, Pasquier D, Debled M, Thery JC, Gonçalves A, Desmoulins I, De La Motte Rouge T, Faure C, Ferrero JM, Eymard JC, Mouret-Reynier MA, Patsouris A, Cottu P, Dalenc F, Petit T, Payen O, Uwer L, Guiu S, Frenel JS. Mallet A, et al. Among authors: petit t. Ther Adv Med Oncol. 2022 Jan 21;14:17588359211070362. doi: 10.1177/17588359211070362. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35082924 Free PMC article.

10

Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results.

Perez EA, López-Vega JM, Petit T, Zamagni C, Easton V, Kamber J, Restuccia E, Andersson M. Perez EA, et al. Among authors: petit t. Breast Cancer Res. 2016 Dec 13;18(1):126. doi: 10.1186/s13058-016-0773-6. Breast Cancer Res. 2016. PMID: 27955684 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

509 results

Search Page